FDG-PET/MRI in patients with pelvic recurrence of rectal cancer: first clinical experiences.
Verena PlodeckNuh N RahbariJuergen WeitzChristoph G RadosaMichael LaniadoRalf-Thorsten HoffmannKlaus ZöphelBettina Beuthien-BaumannJoerg KotzerkeJoerg van den HoffIvan PlatzekPublished in: European radiology (2018)
• Metabolic information obtained from PET coupled with excellent soft tissue contrast from MRI could facilitate detection of rectal cancer recurrence and assist in treatment planning. • PET/MRI demonstrates high sensitivity and specificity for the diagnosis of local recurrence of rectal cancer • PET/MRI led to alterations in management in 18.2% of patients.
Keyphrases
- rectal cancer
- contrast enhanced
- pet ct
- positron emission tomography
- computed tomography
- locally advanced
- magnetic resonance imaging
- pet imaging
- diffusion weighted imaging
- end stage renal disease
- magnetic resonance
- free survival
- soft tissue
- newly diagnosed
- chronic kidney disease
- mental health
- prognostic factors
- peritoneal dialysis
- radiation therapy
- patient reported outcomes
- health information
- social media
- real time pcr